摘要
Journal Article New Avenues for Pharmacological Management of Hyperphagia and Associated Behavioral Disorders in Prader-Willi Syndrome Get access Juan M Castellano, Juan M Castellano Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Cordoba, SpainDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, 14004 Cordoba, SpainPediatric Endocrinology Section, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain Search for other works by this author on: Oxford Academic Google Scholar Ana B Ariza-Jimenez, Ana B Ariza-Jimenez Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Cordoba, SpainCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 14004 Cordoba, Spain Search for other works by this author on: Oxford Academic Google Scholar Manuel Tena-Sempere Manuel Tena-Sempere Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Cordoba, SpainDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, 14004 Cordoba, SpainPediatric Endocrinology Section, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain Correspondence: Manuel Tena-Sempere, MD, PhD, Department of Cell Biology, Physiology & Immunology, Faculty of Medicine, University of Córdoba, Avda. Menéndez Pidal s/n. 14004 Córdoba, Spain. Email: fi1tesem@uco.es. https://orcid.org/0000-0002-4741-5567 Search for other works by this author on: Oxford Academic Google Scholar The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 9, September 2023, Pages e895–e896, https://doi.org/10.1210/clinem/dgad131 Published: 10 March 2023 Article history Received: 01 March 2023 Editorial decision: 02 March 2023 Published: 10 March 2023 Corrected and typeset: 21 March 2023